Answer
No reproductive or fertility studies have been conducted with brolucizumab (Beovu), but VEGF inhibition affects follicular development, corpus luteum function and fertility, indicating a potential risk to female reproduction based on its mechanism of action.
Sources for this answer
- Beovu 120 mg/ml solution for injection in pre filled syringeNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 12Document updated
Sources checked